News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Talha Badar: Efficacy of autologous and allogeneic hematopoietic cell transplantation in Acute Promyelocytic Leukemia
Photo taken from Talha Badar/Twitter
Apr 11, 2024, 15:15

Talha Badar: Efficacy of autologous and allogeneic hematopoietic cell transplantation in Acute Promyelocytic Leukemia

Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter:

“Efficacy of autologous and allogeneic hematopoietic cell transplantation in Acute Promyelocytic Leukemia (APL): systemic review and meta-analysis. A big shout out to Razan Mohty for leading this effort!

Congratulation to all co-authors at Mayo Clinic, Florida.

  • Highlights: 10% of patients experience disease relapse following front-line therapy.
  • Pooled EFS rates for autologous and allogeneic hematopoietic cell transplantation
    are 71% and 54%, respectively.
  • Pooled OS rates for autologous and allogeneic hematopoietic cell transplantation
    are 82% and 58%, respectively.
  • There is a higher risk of pooled NRM rate with an allogeneic hematopoietic cell transplantation (29% vs. 5%).”

Additional information.
Source: Talha Badar/X

Acute Promyelocytic Leukemia (APL) cancer disease relapse EFS hematopoietic cell transplantation Mayo Clinic NRM OncoDaily Oncology Razan Mohty Talha Badar
Special Coverage
Blog
Nov 15, 2024, 08:10
IPOS - Call for the papers for the The Journal of Psychosocial Oncology Research and Practice
Insight
Nov 15, 2024, 08:06
Elisa Agostinetto: Axillary surgery in patients with residual isolated tumor cells after NACT for early breast cancer
Insight
Nov 15, 2024, 07:57
Gabriel Aleixo: Initiating cancer treatment at a lower dose and gradually escalating it
Blog
Nov 15, 2024, 07:51
The incidence of lung cancer and pregnancy - IASLC
Blog
Nov 15, 2024, 07:46
Herbert Loong: CTOS2024 has kicked off
Career
Nov 15, 2024, 07:34
Last chance to apply for Manchester Cancer Research Centre's PhD opportunities for 2025
Insight
Nov 15, 2024, 07:12
Dominique Stuijt: Patient-reported barriers and facilitators to using mHealth during cancer treatment
Blog
Nov 15, 2024, 07:08
Harry Greenspun: Great opening day of the Milken Institute Future's of Health Summit
Insight
Nov 15, 2024, 07:05
Susanna Greer: A New Playbook for Head and Neck Cancer Treatment
Blog
Nov 15, 2024, 07:03
Factors enabling oncologists to cope with work-related stress - ESMO
Celebrities
Nov 15, 2024, 06:53
Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More
Blog
Nov 15, 2024, 06:33
Sendurai Mani: The Power of Determination